Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
申请人:F. HOFFMANN-LA ROCHE LTD
公开号:US20130102600A1
公开(公告)日:2013-04-25
The present invention relates to a compound having the general formula I, optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof,
which is useful in treating, ameliorating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.
本发明涉及一种具有通式I的化合物,可选地以药物可接受的盐、溶剂化物、多晶型、前药、互变异构体、外消旋体、对映体、非对映体或其混合物的形式,该化合物在治疗、改善或预防病毒性疾病方面有用。此外,还公开了特定的组合疗法。